Bayer Raises Enthusiasm about Kerendia Heart and Kidney Disease Drug after SGLT2 Patients see Benefits

It was previously thought that the heart and kidney disease drug Kerendia, was in competition with SGLT2 diabetes medications. However, recent data...

Astellas Pharma’s Fezolinetant Trials Show Positive Results in Reducing Vasomotor Symptoms

For the treatment of moderate to severe Vasomotor Symptoms (VMS) in post-menopausal women, Astellas’ Fezolinetant, has shown efficacious and exceptional topline outcomes...

Takeda Pharmaceutical gets FDA nod for lung cancer drug Exkivity

The U.S. Food and Drug Administration had approved Takeda Pharmaceutical Co.’s drug, Exkivity, to treat a particular type of lung cancer, the...

Ascendis gets FDA nod on once a week pediatric growth hormone deficiency injection

Ascendis Pharma Lonapegsomatropin-tcgd injection, Skytrofa, which is a weekly somatropin formulation, has recently been approved by FDA for children having growth hormone...

Paratek gets FDA’s orphan drug designation for NUZYRA for treating infections caused by Nontuberculous Mycobacteria

The U.S. Food and Drug Administration (FDA), on August 18, 2021, has granted Paratek Pharmaceuticals’ drug, NUZYRA® (omadacycline), an orphan drug designation for...

Pfizer signs agreement to acquire Trillium Therapeutics for $2.26B

Pfizer is all set to acquire a clinical-stage immuno-oncology company, Trillium Therapeutics Inc., with all its outstanding shares, for $2.26 billion (or...

Azurity acquires Arbor Pharmaceuticals to form an integrated entity

Azurity Pharmaceuticals Inc. has signed an agreement for acquiring Georgia based Arbor Pharmaceuticals from its existing equity holders JW Asset Management and...

GW Pharmaceuticals gets MHRA approval for Epidiolex to treat TSC related seizures

A cannabinoid therapeutics developer and part of Jazz Pharmaceuticals plc., GW Pharmaceuticals, on August 10th, 2021, has announced that the U.K. Medicines...

Latest news

Patient-Centric Clinical Trials And The Role Of A Travel Concierge

Many people find booking plane tickets, arranging road transportation and overnight lodging overwhelming. Add into that mix...
- Advertisement -

China forces insulin price cuts resulting in pullback for global pharma players

Xinhua, a Chinese news channel, commented on the price cut on insulin which was brought on by...

Aussie pharma CSL in talks to buy Swiss firm Vifor Pharma for USD 7B

CSL, the Australian giant, is in talks to buy Vifor Pharma in a deal that is valued...

Must read

Surrounded by controversy, FDA approves Biogen’s Alzheimer’s drug Aduhelm

In the middle of the debate about the Alzheimer’s drug approval, the United States FDA has authorized Aduhelm

Amgen’s KRAS drug gets early FDA approval for lung cancer with specific mutation

On Friday, the United States FDA (Food and Drug Administration) has authorized a medication of Amgen Biopharmaceutical in patients with NSCLC

You might also likeRELATED
Recommended to you

KD Pharma Acquires Rohner AG Manufacturing Assets

BIOGGIO, Switzerland-(BUSINESS WIRE)-The KD Pharma Group has acquired the manufacturing assets of the former Rohner AG

Boston Pharmaceuticals and GSK enter pact for advancement of early stage cancer, CNS programs

Boston Pharmaceuticals announced today a pioneering three-year out-license and option agreement

Bayer optimistic about new products increasing sales and earnings

Bayer AG is targeting sales and earnings growth through 2024 as the German drugs and agriculture giant looks past
Nominations for Top Industry Leaders Awards are now open!